Delivery Order SPE2DB24D2216-SPE2DB25FGNXU

Award Date 6/9/25
Potential Completion Date 6/10/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has a ceiling value of $10,085.89 and a completion date of May 29, 2025. It is a firm-fixed-price contract, indicating a predetermined payment amount. The contract is not designated as a set-aside, meaning it was competitively awarded. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Humulin R 500 Unit/mL Kwikpen, a diabetes medication, with a ceiling value of $6,434.52 and a performance period through May 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication, with a ceiling value of $40,910.13 and a period of performance through May 9, 2025. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication, with a firm fixed price ceiling value of $5,698.95 and a performance period through May 28, 2025. The contract is not set aside and is open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has a firm fixed price of $21,817.52 and a period of performance ending on March 6, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,518.18 firm fixed price contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has a performance period through May 9, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication, with a ceiling value of $8,000.54. The contract is a firm fixed price, non-set-aside award with a period of performance through May 20, 2025. Amerisourcebergen Drug Corp is the prime contractor and there is no information...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a pharmaceutical product, with a ceiling value of $4,149.50 and a completion date of April 7, 2025. The contract is a Firm Fixed Price, Delivery Order type, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,807.85 contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has an ultimate completion date of April 23, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humulin R 500 Unit/mL Kwikpen 3mL, a diabetes medication. The contract has a firm-fixed price and is not set aside. The total contract value is $4,531.96, with a period of performance ending on May 6, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D2216
    Indefinite Delivery Contract
  • SPE2DB24D2216-SPE2DB25FGNXU
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has a ceiling value of $11,020.60 and is a firm fixed-price delivery order. It was awarded on June 9, 2025 with a performance period through June 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs.

Generated 9/14/25, 12:48 AM